In Mirai Genomics, we are of the view that early disease diagnostics is of utmost importance, which is why we have been developing POC solutions ensuring the gold standard of PCR laboratories for over 15 years. We believe GenPad is the perfect system for tackling the pandemic.
Prof. Yoshihide Hayashizaki
CEO of K.K. Mirai Genomics
M.D., Ph.D., (h-index 115 as of July 29, 2021)
In-house production of devices, test cartridges, enzymes, polymerases, primers, and other components in accordance with the ISO 13485 highest quality standards.
SmartAmp® key technology is a proprietary next generation molecular technology ensuring the highest level of accuracy.